Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

13.32
Delayed Data
As of 3:59pm ET
 -0.41 / -2.99%
Today’s Change
6.47
Today|||52-Week Range
13.76
+44.78%
Year-to-Date
No recent news for SciClone Pharmaceuticals Inc.

Today’s Trading

Previous close13.73
Today’s open13.56
Day’s range13.17 - 13.67
Volume381,928
Average volume (3 months)474,150
Market cap$681.7M
Dividend yield--
Data as of 3:59pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)+21.43%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+16.67%
P/E ratio23.6
Price/Sales3.05
Price/Book3.78

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc-0.35-1.87%
MGNXMacroGenics Inc-0.80-3.84%
CPXXCelator Pharmaceutic...-0.73-4.77%
KERXKeryx Biopharmaceuti...-0.32-5.37%
Data as of 4:01pm ET, 05/03/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)$0.15
Annual revenue (last year)$157.3M
Annual profit (last year)$29.5M
Net profit margin18.74%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
CFO, Secretary &
SVP-Finance
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts

Partner Offers

Search for Jobs